Literature DB >> 25198422

Resistant hypertension in patients with type 2 diabetes: clinical correlates and association with complications.

Anna Solini1, Giacomo Zoppini, Emanuela Orsi, Cecilia Fondelli, Roberto Trevisan, Monica Vedovato, Franco Cavalot, Olga Lamacchia, Maura Arosio, Marco G Baroni, Giuseppe Penno, Giuseppe Pugliese.   

Abstract

OBJECTIVE: The phenotype of resistant hypertension in patients with type 2 diabetes has been poorly characterized. This cross-sectional analysis of the large cohort from the Renal Insufficiency and Cardiovascular Events (RIACE) study was aimed at assessing the clinical correlates and association with complications of resistant hypertension in patients with type 2 diabetes.
METHODS: The RIACE study enrolled 15,773 patients consecutively visiting 19 diabetes clinics during the years 2007-2008. Resistant hypertension, defined as BP values not on target (i.e. >130/80 mmHg, respectively) with three antihypertensive agents, was detected in 2363 individuals (15% of the whole RIACE cohort, 17.4% of hypertensive individuals, and 21.2% of treated hypertensive patients). Patients without resistant hypertension [nonresistant hypertension (NRH)], that is on target with one (n = 1569), two (n = 1369), and three (n = 803) drugs, and individuals with uncontrolled hypertension, that is untreated or not on target with less than three drugs (n = 7440), served as controls.
RESULTS: As compared with NRH and uncontrolled hypertension patients, patients with resistant hypertension were older and more frequently women and had significantly higher waist circumference, albuminuria, and serum creatinine, and lower glomerular filtration rate. Prevalence values of chronic kidney disease and advanced retinopathy were significantly higher in resistant hypertension than in both nonresistant hypertension and uncontrolled hypertension individuals, whereas cardiovascular disease was more frequent in resistant hypertension versus uncontrolled hypertension, but not nonresistant hypertension patients, especially those on 2-3 drugs.
CONCLUSIONS: Resistant hypertension is relatively common in patients with type 2 diabetes. In these individuals, age, female sex and waist circumference are independent correlates of resistant hypertension, which is strongly associated with microvascular (especially renal) disease, whereas relation with macrovascular complications is unclear.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25198422     DOI: 10.1097/HJH.0000000000000350

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  14 in total

1.  Increased Incidence of Resistant Hypertension in Patients With Systemic Lupus Erythematosus: A Retrospective Cohort Study.

Authors:  Jocelyn S Gandelman; Omair A Khan; Megan M Shuey; Jacquelyn E Neal; Elizabeth McNeer; Alyson Dickson; April Barnado; Li Wang; Prathima Anandi; William D Dupont; C Michael Stein; Cecilia P Chung
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-04       Impact factor: 4.794

2.  Current status of achieving blood pressure target and its clinical correlates in Japanese type 2 diabetes.

Authors:  Hiroki Yokoyama; Shin-Ichi Araki; Koichi Kawai; Koichi Hirao; Yoshio Kurihara; Hiroaki Seino; Hiroshi Takamura; Hidekatsu Sugimoto; Akira Okada; Hiroshi Maegawa
Journal:  J Diabetes Investig       Date:  2017-07-21       Impact factor: 4.232

3.  The Efficacy of Perindopril/Amlodipine in Reaching Blood Pressure Targets: Results of the CONTROL Study.

Authors:  Ayman Abdelhady; Said Khader; Samy Sinnuqrut; Abdullah Albow
Journal:  Clin Drug Investig       Date:  2016-05       Impact factor: 2.859

4.  Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.

Authors:  Francesca Viazzi; Pamela Piscitelli; Antonio Ceriello; Paola Fioretto; Carlo Giorda; Pietro Guida; Giuseppina Russo; Salvatore De Cosmo; Roberto Pontremoli
Journal:  J Am Heart Assoc       Date:  2017-09-22       Impact factor: 5.501

5.  Acarbose Accelerates Wound Healing via Akt/eNOS Signaling in db/db Mice.

Authors:  Xue Han; Yaping Deng; Jiawen Yu; Yuannan Sun; Guofei Ren; Jian Cai; Jianjun Zhu; Guojun Jiang
Journal:  Oxid Med Cell Longev       Date:  2017-03-08       Impact factor: 6.543

6.  Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study.

Authors:  Anna Solini; Giuseppe Penno; Emanuela Orsi; Enzo Bonora; Cecilia Fondelli; Roberto Trevisan; Monica Vedovato; Franco Cavalot; Olga Lamacchia; Marco G Baroni; Antonio Nicolucci; Giuseppe Pugliese
Journal:  BMC Med       Date:  2019-04-25       Impact factor: 8.775

7.  Renal Function Alters Antihypertensive Regimens in Type 2 Diabetic Patients.

Authors:  Larry A Weinrauch; George Bayliss; Alissa R Segal; Jiankang Liu; Eric Wisniewski; John A D'Elia
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-03-02       Impact factor: 3.738

Review 8.  Resistant hypertension-defining the scope of the problem.

Authors:  Richard Chia; Ambarish Pandey; Wanpen Vongpatanasin
Journal:  Prog Cardiovasc Dis       Date:  2019-12-19       Impact factor: 11.278

9.  Resistant hypertension in type 2 diabetes: prevalence and patients characteristics.

Authors:  Dana Mihaela Ciobanu; Hélène Kilfiger; Bogdan Apan; Gabriela Roman; Ioan Andrei Veresiu
Journal:  Clujul Med       Date:  2015-07-01

10.  Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice.

Authors:  Jia-Wen Yu; Ya-Ping Deng; Xue Han; Guo-Fei Ren; Jian Cai; Guo-Jun Jiang
Journal:  Cardiovasc Diabetol       Date:  2016-06-18       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.